The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings

BACKGROUND: In the United States, hepatitis C virus (HCV) infection is most prevalent among adults born from 1945 through 1965, and approximately 50% to 75% of infected adults are unaware of their infection. OBJECTIVE: To estimate the cost-effectiveness of birth-cohort screening. DESIGN: Cost-effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Intern Med
Main Authors: Rein, David B., Smith, Bryce D., Wittenborn, John S., Lesesne, Sarah B., Wagner, Laura D., Roblin, Douglas W., Patel, Nita, Ward, John W., Weinbaum, Cindy M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5484577/
https://ncbi.nlm.nih.gov/pubmed/22056542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/0003-4819-156-4-201202210-00378
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados